Amoytop Biotech (688278) Unveils Comprehensive Pipeline Advancements at First Post-IPO R&D Day
Jun 06, 2026 11:46
CST Updated
12:07
Amoytop Biotech
Developer and Producer of Recombinant Proteins and Their Long-Acting Modified Drugs